cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5281/zenodo.4389243
title: DRIV100 (Diverse Roadscenes from Internet Videos 100)

description: DRIV100 is a dataset for benchmarking unsupervised domain adaptation techniques on in-the-wild road-scene videos. The dataset consists of pixel-level annotations for 100 videos selected from YouTube to cover diverse scenes/domains. We provide multiple manually labeled ground-truth frames for each video, enabling a thorough evaluation of video-level domain adaptation where each video independently serves as the target domain. Please refer to our paper for more details, and please cite it if you use the DRIV100 dataset in your academic research: Haruya Sakashita, Christoph Flothow, Noriko Takemura, and Yusuke Sugano. "DRIV100: In-The-Wild Multi-Domain Dataset and Evaluation for Real-World Domain Adaptation of Semantic Segmentation." <em>arXiv preprint arXiv:2102.00150</em> (2021). https://arxiv.org/abs/2102.00150
DOI: 10.5281/zenodo.4389242
title: DRIV100 (Diverse Roadscenes from Internet Videos 100)

description: DRIV100 is a dataset for benchmarking unsupervised domain adaptation techniques on in-the-wild road-scene videos. The dataset consists of pixel-level annotations for 100 videos selected from YouTube to cover diverse scenes/domains. We provide multiple manually labeled ground-truth frames for each video, enabling a thorough evaluation of video-level domain adaptation where each video independently serves as the target domain. Please refer to our paper for more details, and please cite it if you use the DRIV100 dataset in your academic research: Haruya Sakashita, Christoph Flothow, Noriko Takemura, and Yusuke Sugano. "DRIV100: In-The-Wild Multi-Domain Dataset and Evaluation for Real-World Domain Adaptation of Semantic Segmentation." <em>arXiv preprint arXiv:2102.00150</em> (2021). https://arxiv.org/abs/2102.00150
DOI: 10.18112/openneuro.ds003548.v1.0.0
title: Emotion Category and Face Perception Task Optimized for Multivariate Pattern Analysis
DOI: 10.5517/ccdc.csd.cc25twqm
title: CCDC 2020881: Experimental Crystal Structure Determination

description: Related Article: Yijian Zhao, Qinzhi Wang, Haihua Wang, Hui Zhangsun, Xinyu Sun, Tong Bu, Yingnan Liu, Wenze Wang, Zhihao Xu, Li Wang|2021|Sens.Actuators,B|334|129610|doi:10.1016/j.snb.2021.129610
DOI: 10.6084/m9.figshare.14112356
title: supplemental table 1

description: List of the mRNA and lncRNA primer sequences
DOI: 10.6084/m9.figshare.14112356.v1
title: supplemental table 1

description: List of the mRNA and lncRNA primer sequences
DOI: 10.34740/kaggle/dsv/1955399
title: Wikibooks Dataset
DOI: 10.6084/m9.figshare.14112296
title: Supplementary Material for: Factors Associated with Survival and Survival without Major Morbidity in Very Preterm Infants in Two Neonatal Networks: SEN1500 and NEOCOSUR

description: <b><i>Introduction:</i></b> Very low-birth weight (VLBW) infants represent a high-risk population for morbidity and mortality in the neonatal period. Variability in practices and outcomes between centers has been acknowledged. Multicenter benchmarking studies are useful to detect areas of improvement and constitute an interesting research tool. <b><i>Objectives:</i></b> The aim of the study was to determine the perinatal variables and interventions associated with survival and survival without major morbidity in VLBW infants and compare the performance of 2 large networks. <b><i>Methods:</i></b> This is a prospective study analyzing data collected in 2 databases, the Spanish SEN1500 and the South American NEOCOSUR networks, from January 2013 to December 2016. Inborn patients, from 24<sup>0</sup> to 30<sup>6</sup> weeks of gestational age (GA) were included. Hazard ratios for survival and survival without major morbidity until the first hospital discharge or transfer to another facility were studied by using Cox proportional hazards regression. <b><i>Results:</i></b> A total of 10,565 patients, 6,120 (57.9%) from SEN1500 and 4,445 (42.1%) from NEOCOSUR, respectively, were included. In addition to GA, birth weight, small for gestational age (SGA), female sex, and multiple gestation, less invasive resuscitation, and the network of origin were significant independent factors influencing survival (aHR [SEN1500 vs. NEOCOSUR]: 1.20 [95% CI: 1.15–1.26] and survival without major morbidity: 1.34 [95% CI: 1.26–1.43]). Great variability in outcomes between centers was also found within each network. <b><i>Conclusions:</i></b> After adjusting for covariates, GA, birth weight, SGA, female sex, multiple gestation, less invasive resuscitation, and the network of origin showed an independent effect on outcomes. Determining the causes of these differences deserves further study.
DOI: 10.34740/kaggle/dsv/1974604
title: Contrastive Language Image Pretraining by openai
DOI: 10.13140/rg.2.2.13648.84480
title: Septian anugrah
DOI: 10.6084/m9.figshare.14112080
title: TCR of lung

description: Lung cancer is the leading cause of cancer-related deaths worldwide, and its occurrence is related to the accumulation of gene mutations and immune escape of the tumor. Sequencing of the T cell receptor (TCR) repertoire can reveal the immunosurveillance status of the tumor microenvironment, which is related to tumor escape and immunotherapy. This study aimed to determine the characteristics and clinical significance of the TCR repertoire in lung cancer. To comprehensively profile the TCR repertoire, results from high-throughput sequencing of samples from 93 Chinese lung cancer patients were analyzed. We found that the TCR clonality of tissues was related to smoking, with higher clonality in patients who had quit smoking for less than 1 year. As expected, TCR clonality was correlated with stages, and stage IV patients showed higher clonality than others. The correlation between TCR repertoire and epidermal growth factor receptor (EGFR) status was also investigated. EGFR non-L858R patients showed higher clonality and lower Shannon index than others, including EGFR L858R and EGFR wild-type patients. Further, we analyzed the TCR similarity metrics, that is, the TCR shared between postoperative peripheral blood and tissue, of patients with non-distant metastasis lung cancer. A similar trend was found, with EGFR L858R patients having lower OLI and MOI. Moreover, OLI showed a positive correlation with several clinical characteristics, including the tumor mutational burden of tissues and maximum somatic allele frequency of blood; and OLI showed negative correlation with ratio of CD4+CD28+/CD4+ and ratio of CD8+CD28+/CD8+. In conclusion, TCR clonality and TCR similarity metrics were correlated with clinical characteristics of lung cancer patients, and differences in TCR clonality, Shannon index, and OLI across EGFR subtypes provide information for the potential understanding of the different response to immunotherapy in patients with different EGFR mutations.
DOI: 10.6084/m9.figshare.14112407
title: supplemental table 2

description: Receiver operating characteristic (ROC) data of variables displaying discrimination power for one of top lncRNAs (Gm38501) in calculation of NAFLD activity score (NAS) given as area under the curve (AUC) and 95% confidence interval (CI).
DOI: 10.6084/m9.figshare.14112407.v1
title: supplemental table 2

description: Receiver operating characteristic (ROC) data of variables displaying discrimination power for one of top lncRNAs (Gm38501) in calculation of NAFLD activity score (NAS) given as area under the curve (AUC) and 95% confidence interval (CI).
DOI: 10.6084/m9.figshare.12416081
title: Carbon isotopic and lithologic constraints on the sources and cycling of inorganic carbon in four larger rivers: the Yangtze, Yellow, Pearl, and Heilongjiang in China

description: This data set provides details for concentrations and carbon isotopic (δ<sup>13</sup>C and Δ<sup>14</sup>C) compositions of DIC and Ca<sup>2+</sup>, Mg<sup>2+ </sup>measurements in the water samples collected from the Yangtze, Yellow, Pearl and Heilongjiang in China during 2015-2018. <br>
DOI: 10.6084/m9.figshare.14095461
title: Prevalence of anosmia in the severity of COVID-19 data- Supplementary Table 1

description: For articles on COVID-19 cases that involved anosmia as a variable and distinguished the data in either hospitalized and non-hospitalized patients or severe and non-severe patients untill 31<sup>st</sup> December 2020 (search terms: anosmia/loss of smell/olfactory disorders), an online search of COVID-19 portfolio of the National Institute of Health (https://icite.od.nih.gov/covid19/search/) was performed.<b>Data selection, extraction and synthesis</b>Reports were included if they contained anosmia as a separate variable and patients were characterized in either severe and non-severe patients or hospitalized or non-hospitalized patients with prevalance information on loss of smell. Datas were entered directly into an online structured data extraction table. The estimates represent the odds ratio for loss of smell associated with known severe or non-severe cases and hospitalized or non-hospitalized cases. The proportion of known male infections and odds ratio for severity of COVID-19 infection associated with known male sex are estimated in our additional analyses. For some sources, appropriate grouping of patients were done for the easy analysis.
DOI: 10.6084/m9.figshare.14095461.v2
title: Prevalence of anosmia in the severity of COVID-19 data- Supplementary Table 1

description: For articles on COVID-19 cases that involved anosmia as a variable and distinguished the data in either hospitalized and non-hospitalized patients or severe and non-severe patients untill 31<sup>st</sup> December 2020 (search terms: anosmia/loss of smell/olfactory disorders), an online search of COVID-19 portfolio of the National Institute of Health (https://icite.od.nih.gov/covid19/search/) was performed.<b>Data selection, extraction and synthesis</b>Reports were included if they contained anosmia as a separate variable and patients were characterized in either severe and non-severe patients or hospitalized or non-hospitalized patients with prevalance information on loss of smell. Datas were entered directly into an online structured data extraction table. The estimates represent the odds ratio for loss of smell associated with known severe or non-severe cases and hospitalized or non-hospitalized cases. The proportion of known male infections and odds ratio for severity of COVID-19 infection associated with known male sex are estimated in our additional analyses. For some sources, appropriate grouping of patients were done for the easy analysis.
DOI: 10.6084/m9.figshare.14095461.v1
title: Prevalence of anosmia in the severity of COVID-19 data- Supplementary Table 1

description: For articles on COVID-19 cases that involved anosmia as a variable and distinguished the data in either hospitalized and non-hospitalized patients or severe and non-severe patients untill 31<sup>st</sup> December 2020 (search terms: anosmia/loss of smell/olfactory disorders), an online search of COVID-19 portfolio of the National Institute of Health (https://icite.od.nih.gov/covid19/search/) was performed.<b>Data selection, extraction and synthesis</b>Reports were included if they contained anosmia as a separate variable and patients were characterized in either severe and non-severe patients or hospitalized or non-hospitalized patients with prevalance information on loss of smell. Datas were entered directly into an online structured data extraction table. The estimates represent the odds ratio for loss of smell associated with known severe or non-severe cases and hospitalized or non-hospitalized cases. The proportion of known male infections and odds ratio for severity of COVID-19 infection associated with known male sex are estimated in our additional analyses. For some sources, appropriate grouping of patients were done for the easy analysis.
DOI: 10.6084/m9.figshare.14112980
title: Prevalence of anosmia in the severity of COVID-19 data- Supplementary Table 1

description: For articles on COVID-19 cases that involved anosmia as a variable and distinguished the data in either hospitalized and non-hospitalized patients or severe and non-severe patients untill 31st December 2020 (search terms: anosmia/loss of smell/olfactory disorders), an online search of COVID-19 portfolio of the National Institute of Health (https://icite.od.nih.gov/covid19/search/) was performed.Data selection, extraction and synthesisReports were included if they contained anosmia as a separate variable and patients were characterized in either severe and non-severe patients or hospitalized or non-hospitalized patients with prevalance information on loss of smell. Datas were entered directly into an online structured data extraction table. The estimates represent the odds ratio for loss of smell associated with known severe or non-severe cases and hospitalized or non-hospitalized cases. The proportion of known male infections and odds ratio for severity of COVID-19 infection associated with known male sex are estimated in our additional analyses. For some sources, appropriate grouping of patients were done for the easy analysis.
DOI: 10.6084/m9.figshare.14112980.v2
title: Prevalence of anosmia in the severity of COVID-19 data- Supplementary Table 1

description: For articles on COVID-19 cases that involved anosmia as a variable and distinguished the data in either hospitalized and non-hospitalized patients or severe and non-severe patients untill 31st December 2020 (search terms: anosmia/loss of smell/olfactory disorders), an online search of COVID-19 portfolio of the National Institute of Health (https://icite.od.nih.gov/covid19/search/) was performed.Data selection, extraction and synthesisReports were included if they contained anosmia as a separate variable and patients were characterized in either severe and non-severe patients or hospitalized or non-hospitalized patients with prevalance information on loss of smell. Datas were entered directly into an online structured data extraction table. The estimates represent the odds ratio for loss of smell associated with known severe or non-severe cases and hospitalized or non-hospitalized cases. The proportion of known male infections and odds ratio for severity of COVID-19 infection associated with known male sex are estimated in our additional analyses. For some sources, appropriate grouping of patients were done for the easy analysis.
DOI: 10.6084/m9.figshare.14112980.v1
title: Untitled Item

description: For articles on COVID-19 cases that involved anosmia as a variable and distinguished the data in either hospitalized and non-hospitalized patients or severe and non-severe patients untill 31st December 2020 (search terms: anosmia/loss of smell/olfactory disorders), an online search of COVID-19 portfolio of the National Institute of Health (https://icite.od.nih.gov/covid19/search/) was performed.Data selection, extraction and synthesisReports were included if they contained anosmia as a separate variable and patients were characterized in either severe and non-severe patients or hospitalized or non-hospitalized patients with prevalance information on loss of smell. Datas were entered directly into an online structured data extraction table. The estimates represent the odds ratio for loss of smell associated with known severe or non-severe cases and hospitalized or non-hospitalized cases. The proportion of known male infections and odds ratio for severity of COVID-19 infection associated with known male sex are estimated in our additional analyses. For some sources, appropriate grouping of patients were done for the easy analysis.<br>
DOI: 10.6084/m9.figshare.13473696.v1
title: Deformed wing virus genotypes A and B do not elicit immunologically different responses in naïve honey bee hosts

description: Supplementary data files and raw small RNA reads
DOI: 10.48370/ofd/ilvulx
title: Turzyca wrzosowiskowa (Carex ericetorum Pollich), 6394

description: Herbarium
DOI: 10.5281/zenodo.4561337
title: Dataset from Bedogni F, Testa L, Rubbio AP, Bianchi G, Grasso C, Scandura S, De Marco F, Tusa M, Denti P, Alfieri O, Giordano A, Ferraro P, Bartorelli AL, Mongiardo A, Petronio AS, Giannini C, De Felice F, Baldi C, Castriota F, Adamo M, Masiero G, Godino C, Montorfano M, Tarantini G, Tamburino C. Real-World Safety and Efficacy of Transcatheter Mitral Valve Repair With MitraClip: Thirty-Day Results From the Italian Society of Interventional Cardiology (GIse) Registry Of Transcatheter Treatment of Mitral Valve RegurgitaTiOn (GIOTTO). Cardiovasc Revasc Med. 2020 Sep;21(9):1057-1062. doi: 10.1016/j.carrev.2020.01.002. Epub 2020 Jan 7. PMID: 32001165.

description: Dataset from the article Bedogni F, Testa L, Rubbio AP, Bianchi G, Grasso C, Scandura S, De Marco F, Tusa M, Denti P, Alfieri O, Giordano A, Ferraro P, Bartorelli AL, Mongiardo A, Petronio AS, Giannini C, De Felice F, Baldi C, Castriota F, Adamo M, Masiero G, Godino C, Montorfano M, Tarantini G, Tamburino C. Real-World Safety and Efficacy of Transcatheter Mitral Valve Repair With MitraClip: Thirty-Day Results From the Italian Society of Interventional Cardiology (GIse) Registry Of Transcatheter Treatment of Mitral Valve RegurgitaTiOn (GIOTTO). Cardiovasc Revasc Med. 2020 Sep;21(9):1057-1062. doi: 10.1016/j.carrev.2020.01.002. Epub 2020 Jan 7. PMID: 32001165. This is the abstract: Background: Available scientific evidence of transcatheter mitral valve repair with the MitraClip comes from randomized controlled trials, which showed controversial results that hardly translate into real-world practice, and from registries of relatively small sample size. Aim: To collect real-world data in a multicenter, prospective, country-level registry. Methods and result: The Italian Society of Interventional Cardiology (GIse) Registry Of Transcatheter Treatment of Mitral Valve RegurgitaTiOn (GIOTTO) is an ongoing single-arm, multicenter, prospective registry that started enrollment in February 2016. Clinical end points were defined according to the Mitral Valve Academic Research Consortium (MVARC) criteria. From February 2016 to December 2018, 1189 patients (mean age 76 ± 9.1 years) were enrolled. The main MR etiology was functional (64.9%). MVARC technical success was 96.6%. At 30-day follow-up (n = 1131), MVARC device and procedural success were 92.5% and 87% respectively, and all-cause death was 3%. The majority of patients who died at 30-day had functional MR (69.7%). Mixed etiology (OR 0.94, 95% CI 0.02-0.61) and prolonged length of stay in ICU (OR 0.97, 95% CI 0.95-0.99) were found to be negative independent predictors of device success at 30-day. The EuroSCORE II (OR 0.96, 95% CI 0.93-0.99), LVEDV-I (OR 0.99, 95% CI 0.98-0.99) and prolonged length of stay in ICU (OR 0.98, 95% CI 0.97-0.99) were negative independent factors of MVARC procedural success at 30-day. Conclusions: The GIOTTO registry is one of the largest prospective registries available on MitraClip and shows favorable acute and 30-day safety and efficacy.
DOI: 10.5281/zenodo.4561336
title: Dataset from Bedogni F, Testa L, Rubbio AP, Bianchi G, Grasso C, Scandura S, De Marco F, Tusa M, Denti P, Alfieri O, Giordano A, Ferraro P, Bartorelli AL, Mongiardo A, Petronio AS, Giannini C, De Felice F, Baldi C, Castriota F, Adamo M, Masiero G, Godino C, Montorfano M, Tarantini G, Tamburino C. Real-World Safety and Efficacy of Transcatheter Mitral Valve Repair With MitraClip: Thirty-Day Results From the Italian Society of Interventional Cardiology (GIse) Registry Of Transcatheter Treatment of Mitral Valve RegurgitaTiOn (GIOTTO). Cardiovasc Revasc Med. 2020 Sep;21(9):1057-1062. doi: 10.1016/j.carrev.2020.01.002. Epub 2020 Jan 7. PMID: 32001165.

description: Dataset from the article Bedogni F, Testa L, Rubbio AP, Bianchi G, Grasso C, Scandura S, De Marco F, Tusa M, Denti P, Alfieri O, Giordano A, Ferraro P, Bartorelli AL, Mongiardo A, Petronio AS, Giannini C, De Felice F, Baldi C, Castriota F, Adamo M, Masiero G, Godino C, Montorfano M, Tarantini G, Tamburino C. Real-World Safety and Efficacy of Transcatheter Mitral Valve Repair With MitraClip: Thirty-Day Results From the Italian Society of Interventional Cardiology (GIse) Registry Of Transcatheter Treatment of Mitral Valve RegurgitaTiOn (GIOTTO). Cardiovasc Revasc Med. 2020 Sep;21(9):1057-1062. doi: 10.1016/j.carrev.2020.01.002. Epub 2020 Jan 7. PMID: 32001165. This is the abstract: Background: Available scientific evidence of transcatheter mitral valve repair with the MitraClip comes from randomized controlled trials, which showed controversial results that hardly translate into real-world practice, and from registries of relatively small sample size. Aim: To collect real-world data in a multicenter, prospective, country-level registry. Methods and result: The Italian Society of Interventional Cardiology (GIse) Registry Of Transcatheter Treatment of Mitral Valve RegurgitaTiOn (GIOTTO) is an ongoing single-arm, multicenter, prospective registry that started enrollment in February 2016. Clinical end points were defined according to the Mitral Valve Academic Research Consortium (MVARC) criteria. From February 2016 to December 2018, 1189 patients (mean age 76 ± 9.1 years) were enrolled. The main MR etiology was functional (64.9%). MVARC technical success was 96.6%. At 30-day follow-up (n = 1131), MVARC device and procedural success were 92.5% and 87% respectively, and all-cause death was 3%. The majority of patients who died at 30-day had functional MR (69.7%). Mixed etiology (OR 0.94, 95% CI 0.02-0.61) and prolonged length of stay in ICU (OR 0.97, 95% CI 0.95-0.99) were found to be negative independent predictors of device success at 30-day. The EuroSCORE II (OR 0.96, 95% CI 0.93-0.99), LVEDV-I (OR 0.99, 95% CI 0.98-0.99) and prolonged length of stay in ICU (OR 0.98, 95% CI 0.97-0.99) were negative independent factors of MVARC procedural success at 30-day. Conclusions: The GIOTTO registry is one of the largest prospective registries available on MitraClip and shows favorable acute and 30-day safety and efficacy.
DOI: 10.6084/m9.figshare.14113016
title: Supplementary Material for: Effects of Maternal Abdominal Surgery on Fetal Brain Development in the Rabbit Model

description: <b><i>Introduction:</i></b> Anesthesia during pregnancy can impair fetal neurodevelopment, but effects of surgery remain unknown. The aim is to investigate effects of abdominal surgery on fetal brain development. Hypothesis is that surgery impairs outcome. <b><i>Methods:</i></b> Pregnant rabbits were randomized at 28 days of gestation to 2 h of general anesthesia (sevoflurane group, <i>n</i> = 6) or to anesthesia plus laparoscopic appendectomy (surgery group, <i>n</i> = 13). On postnatal day 1, neurobehavior of pups was assessed and brains harvested. Primary outcome was neuron density in the frontal cortex, and secondary outcomes included neurobehavioral assessment and other histological parameters. <b><i>Results:</i></b> Fetal survival was lower in the surgery group: 54 versus 100% litters alive at birth (<i>p</i> = 0.0442). In alive litters, pup survival until harvesting was 50 versus 69% (<i>p</i> = 0.0352). No differences were observed for primary outcome (<i>p</i> = 0.5114) for surviving pups. Neuron densities were significantly lower in the surgery group in the caudate nucleus (<i>p</i> = 0.0180), but not different in other regions. No differences were observed for secondary outcomes. Conclusions did not change after adjustment for mortality. <b><i>Conclusion:</i></b> Abdominal surgery in pregnant rabbits at a gestational age corresponding to the end of human second trimester results in limited neurohistological changes but not in neurobehavioral impairments. High intrauterine mortality limits translation to clinical scenario, where fetal mortality is close to zero.
DOI: 10.15468/jrhnqg
title: Tangguoa gen. nov., one new genus of daddy-long-leg spiders (Araneae: Pholcidae) from southern China

description: This dataset contains the digitized treatments in Plazi based on the original journal article Yao, Zhiyuan, Luo, Yiping, Li, Shuqiang (2021): Tangguoa gen. nov., one new genus of daddy-long-leg spiders (Araneae: Pholcidae) from southern China. Zootaxa 4938 (1): 131-140, DOI: https://doi.org/10.11646/zootaxa.4938.1.7